DDXClass I
Plasminogen, Antigen, Antiserum, Control
21 CFR 866.5715 / Immunology
DDX is the FDA product code for Plasminogen, Antigen, Antiserum, Control, a class I device type, regulated under 21 CFR 866.5715. As of , FDA records hold 10 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- DDX
- Device name
- Plasminogen, Antigen, Antiserum, Control
- Regulation
- 21 CFR 866.5715
- Device class
- Class I
- Review panel
- Immunology
- Submission type
- 510(k) exempt
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 10
- Ingested recalls
- 0
Clearances, product code DDX
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1978 | 2 |
| 1981 | 2 |
| 1983 | 1 |
| 1985 | 1 |
| 1986 | 2 |
| 1989 | 1 |
| 1994 | 1 |
Applicants with the most clearances
Product code DDX| Applicant | Clearances |
|---|---|
| Behring Diagnostics, Inc. | 1 |
| Dade, Baxter Travenol Diagnostics, Inc. | 1 |
| E.I. Dupont de Nemours & Co., Inc. | 1 |
| Helena Laboratories, Corp. | 1 |
| Hyland Therapeutic Div., Travenol Laboratories | 1 |
| Instrumentation Laboratory Co. | 1 |
| Kabivitrum, Inc. | 1 |
| The Binding Site | 1 |
| Warner-Lambert Co. | 1 |
| Wellcome Diagnostics | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
